First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
Recruiting · NCT06934538 · Registry updated 2025-12-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer | Unresectable Locally Advanced Colorectal Cancer; Unresectable Metastatic Colorectal Cancer | Recruiting | Phase 1 / Phase 2 | 2025-12-22 | NCT06934538 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Brenus Pharma | 1 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Georges François Leclerc (CGFL) | Dijon | France | 1 |
| Centre Hospitalier Universitaire de Poitiers (CHU) | Poitiers | France | 1 |
| Centre Léon Bérard (CLB) | Lyon | France | 2 |
| Hospices Civils de Lyon (HCL) | Lyon | France | 2 |
| Institut Bergonié | Bordeaux | France | 47 |
| Institut du Cancer de Montpellier (ICM) | Montpellier | France | 2 |
| Institut Gustave Roussy (IGR) | Villejuif | France | 1 |
| Institut Jules Bordet | Brussels | Belgium | 23 |
| Johns Hopkins | Baltimore | United States | 39 |